CinCor Pharma
James Hui possesses extensive experience in clinical pharmacology and translational research, currently serving as Vice President of Clinical Pharmacology and Translational Research at CinCor Pharma, Inc. Prior roles include Senior Director of Clinical Pharmacology at Alexion Pharmaceuticals (AstraZeneca Rare Disease), Executive Director of Clinical Pharmacology at Achillion Pharmaceuticals, and Scientific Director of Drug Metabolism/Pharmacokinetics & Pharmaceutics at Genzyme. James also held the position of Director of Bioanalytical Chemistry at Gilead Sciences. Academic credentials include a Ph.D. in Drug Metabolism & Pharmacokinetics from The Ohio State University and a B.Sc.Phm. in Pharmacy from the University of Toronto.
This person is not in any offices
CinCor Pharma
CinCor is a clinical-stage cardiorenal therapeutics company with a novel clinical-stage candidate, CIN-107 that has the potential to dramatically expand therapeutic options for patients suffering from hypertension and its associated risks.